Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Advent Access logo — Unlocking the Future of Dialysis

Advent Access

Unlocking the Future of Dialysis

Founded 2015 Singapore Singapore 1 employees Seed Total: $2.60M Health Care, Medical Devices

General Information

Company Name Advent Access
Founded Year 2015
Location Singapore Singapore
Founders / Decision Makers
Team member
Employees 1
Industries Health Care, Medical Devices
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Advent Access. To contact Advent Access, visit adventaccess.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Advent Access compare?

A PDF of Advent Access and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Advent Access soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Advent Access

Advent Access is a medical technology startup based in Singapore that is dedicated to revolutionizing end-stage renal disease management. The company's flagship product, the av-Guardian™, is an innovative implant technology designed to enhance vascular access reliability for dialysis patients. This technology not only aims to reduce dialysis costs but also to improve the overall quality of life for individuals suffering from kidney failure. Additionally, the av-Guardian™ facilitates less painful self-cannulation, potentially lowering vascular access-related hospitalizations. Founded in 2015, Advent Access has garnered significant attention within the industry. It has already secured over $5.6M in private investments and research grants. In December 2017, the company closed a SGD2.60M Seed Round investment, with Advanced Medtech participating as the primary investor. It is worth noting that the company's management team and investors collectively possess extensive experience, having pioneered over ten startups in the medtech sector, along with a track record of successful IPOs and exits. Advent Access's commitment to empowering dialysis patients aligns with the growing trend towards personalized and accessible healthcare. By offering a dialysis-machine agnostic platform, the company aims to enable patients to conduct hemodialysis independently and affordably, whether at home or in alternative care environments. As a Stanford StartX company and a spin-off from A*STAR, Advent Access is well-positioned to drive significant advancements in renal care, fulfilling its slogan of "Unlocking the Future of Dialysis." For further details, visit www.adventaccess.com.

Taxonomy: Medical Technology, End-Stage Renal Disease, Dialysis Management, Vascular Access, Implant Technology, Home Dialysis, Medtech Startup, Biodesign, Healthcare Innovation, Investment, Stanford StartX, A*STAR, Hemodialysis, Patient Empowerment, Healthcare Quality Improvement

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round SGD2.60M 1
Advanced Medtech
Advanced Medtech
12 Dec 2017

Advent Access Alternatives & Competitors

View All Alternatives
Advent Access vs
Access for Life
Access for Life United States

The JEM represents an innovative breakthrough in the field of repetitive vascular accessand real-tim...

Non Equity Assistance
9 employees
Biotechnology, Health Care
Advent Access vs
Byonyks
Byonyks United States

Bloodless Dialysis

Convertible Note
76 employees
Health Care, Medical Devices
Compare Advent Access vs Byonyks
Advent Access vs
InnAVasc Medical, Inc.
InnAVasc Medical, Inc. United States

Innovating to protect dialysis patients

Debt Financing
1 employees
Health Care, Manufacturing
View all alternatives

FAQ About Advent Access

Unlocking the Future of Dialysis
Advent Access was founded in 2015.
Advent Access is headquartered in Singapore.
Advent Access operates in Health Care and Medical Devices. Its work centres on Medical Technology, End-Stage Renal Disease, Dialysis Management and Vascular Access.
Advent Access has approximately 1 employees.
Advent Access has completed 1 funding round, raising a total of $2.60M. The latest funding stage is Seed.
Top alternatives and competitors to Advent Access include Access for Life, Byonyks, InnAVasc Medical, Inc., EXORENAL, Diality. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Advent Access and Access for Life are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Advent Access, https://bouncewatch.com/company/advent-access, updated 12 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes